THD Internal Medicine Grand Rounds - Cardiac Amyloidosis: The Zebra is Losing its Stripes
Target Audience
This online educational enduring material is designed for physicians and clinical staff. Its purpose is to provide for the continuous educational need of the physicians to become more knowledgeable about the diseases in internal medicine subspecialties and become more efficient in the evaluation and management of concerns unique to their patients.
Learning Objectives
At the end of this online enduring material, participants should be able to:
- Identify the pathophysiologic, prognostic, and clinical differences between light-chain cardiac amyloidosis (AL) and transthyretin cardiac amyloidosis (ATTR).
- Discuss the importance of determining whether ATTR is either hereditary (ATTRm) or wild-type (ATTRwt) and understand the diversity in their clinical presentations.
- Review the clinical clues that might be consistent with a diagnosis of cardiac amyloidosis.
Available Credit
- 1.00 AMA PRA Category 1 Credit™
In support of improving patient care, Texas Health Resources is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
The Texas Health Resources designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. - 1.00 Attendance
- 1.00 Nursing Contact Hour(s)In support of improving patient care, Texas Health Resources is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.